181 related articles for article (PubMed ID: 25198661)
1. A phase II trial of Endostar combined with gemcitabine and cisplatin chemotherapy in patients with metastatic nasopharyngeal carcinoma (NCT01612286).
Jin T; Li B; Chen XZ
Oncol Res; 2013; 21(6):317-23. PubMed ID: 25198661
[TBL] [Abstract][Full Text] [Related]
2. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Fang W; Yang Y; Ma Y; Hong S; Lin L; He X; Xiong J; Li P; Zhao H; Huang Y; Zhang Y; Chen L; Zhou N; Zhao Y; Hou X; Yang Q; Zhang L
Lancet Oncol; 2018 Oct; 19(10):1338-1350. PubMed ID: 30213452
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Zhang L; Huang Y; Hong S; Yang Y; Yu G; Jia J; Peng P; Wu X; Lin Q; Xi X; Peng J; Xu M; Chen D; Lu X; Wang R; Cao X; Chen X; Lin Z; Xiong J; Lin Q; Xie C; Li Z; Pan J; Li J; Wu S; Lian Y; Yang Q; Zhao C
Lancet; 2016 Oct; 388(10054):1883-1892. PubMed ID: 27567279
[TBL] [Abstract][Full Text] [Related]
4. A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update.
Li Y; Tian Y; Jin F; Wu W; Long J; Ouyang J; Zhou Y
Curr Probl Cancer; 2020 Feb; 44(1):100492. PubMed ID: 32035692
[TBL] [Abstract][Full Text] [Related]
5. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
Liu GY; Ye YF; Jiang YF; Chen GJ; Xia WX; Huang YS; Gao TS; Liu YM; Hou YT; Li JF; Liu JH; Lu N; Chen CL; Ke LR; Liang H; Bei WX; Li WZ; Dong SH; Liu Q; Xie C; Yao HR; Xiang YQ
BMJ; 2024 Jun; 385():e077890. PubMed ID: 38897625
[TBL] [Abstract][Full Text] [Related]
6. A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma.
You B; Le Tourneau C; Chen EX; Wang L; Jarvi A; Bharadwaj RR; Kamel-Reid S; Perez-Ordonez B; Mann V; Siu LL
Am J Clin Oncol; 2012 Jun; 35(3):255-60. PubMed ID: 21358293
[TBL] [Abstract][Full Text] [Related]
7. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.
Ngan RK; Yiu HH; Lau WH; Yau S; Cheung FY; Chan TM; Kwok CH; Chiu CY; Au SK; Foo W; Law CK; Tse KC
Ann Oncol; 2002 Aug; 13(8):1252-8. PubMed ID: 12181249
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
Wu M; Ou D; He X; Hu C
Oral Oncol; 2017 Oct; 73():118-123. PubMed ID: 28939063
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma.
Kang M; Wang F; Liao X; Zhou P; Wang R
Medicine (Baltimore); 2018 Jun; 97(25):e11118. PubMed ID: 29924009
[TBL] [Abstract][Full Text] [Related]
10. Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update.
Jin T; Jiang F; Jin QF; Piao YF; Chen XZ
Transl Oncol; 2018 Apr; 11(2):286-291. PubMed ID: 29413761
[TBL] [Abstract][Full Text] [Related]
11. Influence of different drug delivery methods for Endostar combined with a gemcitabine/cisplatin regimen in locally advanced or metastatic lung squamous cell carcinoma: A retrospective observational study.
Yao D; Shen H; Huang J; Yuan Y; Dai H
Medicine (Baltimore); 2018 Aug; 97(32):e11822. PubMed ID: 30095656
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Gao Y; Huang HQ; Bai B; Cai QC; Wang XX; Cai QQ
Expert Opin Pharmacother; 2014 Feb; 15(2):163-71. PubMed ID: 24295173
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.
Ma BB; Tannock IF; Pond GR; Edmonds MR; Siu LL
Cancer; 2002 Dec; 95(12):2516-23. PubMed ID: 12467065
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study.
Jiang Y; Wei YQ; Luo F; Zou LQ; Liu JY; Peng F; Huang MJ; He QM
Cancer Invest; 2005; 23(2):123-8. PubMed ID: 15813504
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination.
Leong SS; Wee J; Tay MH; Toh CK; Tan SB; Thng CH; Foo KF; Lim WT; Tan T; Tan EH
Cancer; 2005 Feb; 103(3):569-75. PubMed ID: 15611975
[TBL] [Abstract][Full Text] [Related]
16. Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma.
Gu MF; Liu LZ; He LJ; Yuan WX; Zhang R; Luo GY; Xu GL; Zhang HM; Yan CX; Li JJ
Int J Cancer; 2013 Jan; 132(1):215-23. PubMed ID: 22610788
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial.
Hsieh JC; Hsu CL; Ng SH; Wang CH; Lee KD; Lu CH; Chang YF; Hsieh RK; Yeh KH; Hsiao CH; Chen SY; Shiau CY; Wang HM
Jpn J Clin Oncol; 2015 Sep; 45(9):819-27. PubMed ID: 26056323
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study.
Kong XY; Lu JX; Yu XW; Zhang J; Xu QL; Zhang RJ; Mi JL; Liao SF; Fan JF; Qin XL; Yao DC; Tang HY; Jiang W
Cancer Chemother Pharmacol; 2019 Jul; 84(1):155-161. PubMed ID: 31087135
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Am J Clin Oncol; 2005 Oct; 28(5):464-71. PubMed ID: 16199985
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.
Li YH; Wang FH; Jiang WQ; Xiang XJ; Deng YM; Hu GQ; Xu DM; Chen Y; Lin Q; He YJ
Cancer Chemother Pharmacol; 2008 Aug; 62(3):539-44. PubMed ID: 18172651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
